皮肤癌中的TRP通道:关注恶性黑色素瘤
Damian Twardak1, Vita Havryliuk1, Maciej Gagat1,2
1Department of Histology and Embryology, Faculty of Medicine, Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, 85-092 Bydgoszcz, Poland.
International journal of molecular sciences
|August 28, 2025
概括
在皮肤癌 (黑色素瘤) 的发展过程中,短暂受体潜能 (TRP) 道至关重要. 它们作为瘤抑制剂或瘤基因的复杂作用突显了向黑色素瘤治疗的潜力.
科学领域:
- 癌症学
- 皮肤病学
- 分子生物学
- 离子通道生理学
背景情况:
- 皮肤恶性黑色素瘤是一种具有高转移潜力的侵袭性皮肤癌.
- 暂时受体潜能 (TRP) 通道调节平衡和细胞应激反应.
- 越来越多地认识到TRP道在黑色素瘤发病过程中的作用.
研究的目的:
- 审查黑色素细胞和黑色素瘤中关键的TRP通道子家族的表达和功能.
- 讨论黑色素瘤进展中的TRP通道失调.
- 评估TRP通道作为潜在的黑色素瘤诊断生物标志物和治疗点.
主要方法:
- 在黑色素瘤中TRP通道表达和功能的文献综述.
- 对黑色素瘤细胞增殖,细胞亡和转移的TRP通道参与的分析.
- 对TRP道向疗法的当前药理策略和研究挑战的评估.
主要成果:
- 特定的TRP通道 (TRPM1,TRPM7,TRPM8,TRPV1,TRPV4,TRPM2) 在黑色素细胞中表达,在黑色素瘤中失调.
- TRPM1充当瘤抑制剂,而TRPM7,TRPV1和TRPV4则具有取决于环境的作用.
- 在氧化和代谢压力下,TRPM2支持黑色素瘤细胞的生存.
结论:
- 黑色素瘤中的TRP通道功能复杂且异形特异.
- 在新型黑色素瘤诊断和治疗方面,TRP道是有前途的标.
- 有效治疗黑色素瘤需要针对特定TRP通道异型的个性化治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Skin Cancer
4.5K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.5K
Enzyme-linked Receptors
79.9K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
79.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Intrinsic Apoptotic Pathway
6.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K


